Abivax SA (AAVXF)
15.15
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Abivax Market Cap: 953.20M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 953.20M |
May 02, 2024 | 953.20M |
May 01, 2024 | 953.20M |
April 30, 2024 | 953.20M |
April 29, 2024 | 953.20M |
April 26, 2024 | 953.20M |
April 25, 2024 | 953.20M |
April 24, 2024 | 953.20M |
April 23, 2024 | 953.20M |
April 22, 2024 | 953.20M |
April 19, 2024 | 688.95M |
April 18, 2024 | 688.95M |
April 17, 2024 | 688.95M |
April 16, 2024 | 688.95M |
April 15, 2024 | 688.95M |
April 12, 2024 | 688.95M |
April 11, 2024 | 688.95M |
April 10, 2024 | 688.95M |
April 09, 2024 | 688.95M |
April 08, 2024 | 688.95M |
April 05, 2024 | 688.95M |
April 04, 2024 | 688.95M |
April 03, 2024 | 688.95M |
April 02, 2024 | 688.95M |
April 01, 2024 | 688.95M |
Date | Value |
---|---|
March 28, 2024 | 688.95M |
March 27, 2024 | 688.95M |
March 26, 2024 | 688.95M |
March 25, 2024 | 688.95M |
March 22, 2024 | 688.95M |
March 21, 2024 | 688.95M |
March 20, 2024 | 688.95M |
March 19, 2024 | 688.95M |
March 18, 2024 | 688.95M |
March 15, 2024 | 688.95M |
March 14, 2024 | 688.95M |
March 13, 2024 | 688.95M |
March 12, 2024 | 688.95M |
March 11, 2024 | 688.95M |
March 08, 2024 | 688.95M |
March 07, 2024 | 688.95M |
March 06, 2024 | 688.95M |
March 05, 2024 | 688.95M |
March 04, 2024 | 688.95M |
March 01, 2024 | 688.95M |
February 29, 2024 | 688.95M |
February 28, 2024 | 688.95M |
February 27, 2024 | 688.95M |
February 26, 2024 | 688.95M |
February 23, 2024 | 688.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
81.84M
Minimum
Jun 28 2019
953.20M
Maximum
Apr 22 2024
396.11M
Average
326.04M
Median
Jul 14 2020
Market Cap Benchmarks
DBV Technologies SA | 129.22M |
Cellectis SA | 230.97M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 184.49M |
Innate Pharma SA | 205.78M |
Market Cap Related Metrics
PEG Ratio | -0.0372 |
Price to Book Value | 4.399 |
Price | 15.15 |
Earnings Yield | -23.37% |
PEGY Ratio | -0.0372 |